MedPath

NERVINEX 125 mg COMPRIMIDOS

NERVINEX 125 mg COMPRIMIDOS

Commercialized
Register Number

64917

Prescription Type

Medicamento Sujeto A Prescripción Médica

Authorization Date

Jul 17, 2002

Dosage Form

COMPRIMIDO

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number64917
EMA Approved
No

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

BRIVUDINAActive
Quantity: 125 mg
Name: BRIVUDINA

ATC CLASSIFICATION (3)

J05A
J05AB
J05AB15

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.